Permeability and biocompatibility evaluation of olopatadine hydrochloride viscous ophthalmic solutions using in vitro 3D corneal model
Само за регистроване кориснике
2021
Аутори
Račić, AnđelkaJurišić Dukovski, Bisera
Lovrić, Jasmina
Dobričić, Vladimir
Čalija, Bojan
Milić, Jela
Krajišnik, Danina
Конференцијски прилог (Објављена верзија)
Метаподаци
Приказ свих података о документуАпстракт
Olopatadine is a selective H1-receptore antagonist that
inhibits release of histamine and proinflammatory
mediators [1]. The poor ocular bioavailability, as the main
limitation of efficient ocular therapy, could be overcome by
increasing residence time and enhancing corneal
penetration. ...
Извор:
12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 11-14 May 2021, Vienna, Austria, Virtual meeting, 2021Издавач:
- International Association for Pharmaceutical Technology, Mainz, Germany
Финансирање / пројекти:
- Развој микро- и наносистема као носача за лекове са антиинфламаторним деловањем и метода за њихову карактеризацију (RS-MESTD-Technological Development (TD or TR)-34031)
- CEEPUS network CIII-RS-1113-03-1920-M-132469
Напомена:
- Saopštenje štampano u celini
Институција/група
PharmacyTY - CONF AU - Račić, Anđelka AU - Jurišić Dukovski, Bisera AU - Lovrić, Jasmina AU - Dobričić, Vladimir AU - Čalija, Bojan AU - Milić, Jela AU - Krajišnik, Danina PY - 2021 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/5481 AB - Olopatadine is a selective H1-receptore antagonist that inhibits release of histamine and proinflammatory mediators [1]. The poor ocular bioavailability, as the main limitation of efficient ocular therapy, could be overcome by increasing residence time and enhancing corneal penetration. ... PB - International Association for Pharmaceutical Technology, Mainz, Germany C3 - 12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 11-14 May 2021, Vienna, Austria, Virtual meeting T1 - Permeability and biocompatibility evaluation of olopatadine hydrochloride viscous ophthalmic solutions using in vitro 3D corneal model UR - https://hdl.handle.net/21.15107/rcub_farfar_5481 ER -
@conference{ author = "Račić, Anđelka and Jurišić Dukovski, Bisera and Lovrić, Jasmina and Dobričić, Vladimir and Čalija, Bojan and Milić, Jela and Krajišnik, Danina", year = "2021", abstract = "Olopatadine is a selective H1-receptore antagonist that inhibits release of histamine and proinflammatory mediators [1]. The poor ocular bioavailability, as the main limitation of efficient ocular therapy, could be overcome by increasing residence time and enhancing corneal penetration. ...", publisher = "International Association for Pharmaceutical Technology, Mainz, Germany", journal = "12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 11-14 May 2021, Vienna, Austria, Virtual meeting", title = "Permeability and biocompatibility evaluation of olopatadine hydrochloride viscous ophthalmic solutions using in vitro 3D corneal model", url = "https://hdl.handle.net/21.15107/rcub_farfar_5481" }
Račić, A., Jurišić Dukovski, B., Lovrić, J., Dobričić, V., Čalija, B., Milić, J.,& Krajišnik, D.. (2021). Permeability and biocompatibility evaluation of olopatadine hydrochloride viscous ophthalmic solutions using in vitro 3D corneal model. in 12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 11-14 May 2021, Vienna, Austria, Virtual meeting International Association for Pharmaceutical Technology, Mainz, Germany.. https://hdl.handle.net/21.15107/rcub_farfar_5481
Račić A, Jurišić Dukovski B, Lovrić J, Dobričić V, Čalija B, Milić J, Krajišnik D. Permeability and biocompatibility evaluation of olopatadine hydrochloride viscous ophthalmic solutions using in vitro 3D corneal model. in 12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 11-14 May 2021, Vienna, Austria, Virtual meeting. 2021;. https://hdl.handle.net/21.15107/rcub_farfar_5481 .
Račić, Anđelka, Jurišić Dukovski, Bisera, Lovrić, Jasmina, Dobričić, Vladimir, Čalija, Bojan, Milić, Jela, Krajišnik, Danina, "Permeability and biocompatibility evaluation of olopatadine hydrochloride viscous ophthalmic solutions using in vitro 3D corneal model" in 12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 11-14 May 2021, Vienna, Austria, Virtual meeting (2021), https://hdl.handle.net/21.15107/rcub_farfar_5481 .